Bulevirtide
Bulevirtide, sold under the brand name Hepcludex, is an antiviral medication for the treatment of chronic hepatitis D (in the presence of hepatitis B). The most common side effects include raised levels of bile salts in the blood and reactions at the site of injection. Bulevirtide works by attaching to and blocking a receptor (target) through which the hepatitis delta and hepatitis B viruses enter liver cells. By blocking the entry of the virus into the cells, it limits the ability of HDV to replicate and its effects in the body, reducing symptoms of the disease.
medication
Wikipage redirect
medication
primaryTopic
Bulevirtide
Bulevirtide, sold under the brand name Hepcludex, is an antiviral medication for the treatment of chronic hepatitis D (in the presence of hepatitis B). The most common side effects include raised levels of bile salts in the blood and reactions at the site of injection. Bulevirtide works by attaching to and blocking a receptor (target) through which the hepatitis delta and hepatitis B viruses enter liver cells. By blocking the entry of the virus into the cells, it limits the ability of HDV to replicate and its effects in the body, reducing symptoms of the disease.
has abstract
Bulevirtide, sold under the br ...... e European Union in July 2020.
@en
alternative name
Hepcludex
@en
CAS number
2012558-47-1
ChEMBL
DrugBank
FDA UNII code
WKM56H3TLB
Link from a Wikipage to an external page
Wikipage page ID
64,773,249
page length (characters) of wiki page
Wikipage revision ID
1,019,161,869
Link from a Wikipage to another Wikipage
ATC prefix
J05
@en
ATC suffix
AX28
@en
CAS number
ChEMBL
DrugBank
DB15248
@en
index2 label
as salt
@en
KEGG
D11877
@en
D11878
@en
legal EU
Rx-only
@en
license EU
yes
@en
routes of administration
synonyms
MyrB, Myrcludex-B
@en
tradename
Hepcludex
@en
UNII
WKM56H3TLB
@en
wikiPageUsesTemplate
comment
Bulevirtide, sold under the br ...... ucing symptoms of the disease.
@en
label
Bulevirtide
@en